Epilepsy is characterized as a central nervous system disorder with uncontrollable twitching of the arms or legs and/or seizures. The Epilepsy Foundation has stated 1 – 26 Americans will develop epilepsy in their lifetime. Convention treatment is medications and sometimes surgery.
Clinical data establishing effective treatment using cannabinoids for this in adults is not well documented at this time, there are many anecdotal accounts of cannabis relieving epileptic symptoms. In recent years, clinicians have began focusing on the ability of CBD’s to mitigate symptoms pediatric epilepsy after these accounts gained massive media attention.
In 2013, the USDA granted “orphan drug status” -which is defined as those intended for the safe and effective treatment, diagnosis or prevention of rare diseases/disorders that affect fewer than 200,000 people in the U.S (www.fda.gov), to imported, pharmaceutically standardized CBD extracts for use in pediatric treatment.
Clinical trials to test the safety and efficacy with severe forms of the disease such as “Dravet syndrome will begin in 2014.
For more information and links to references, check out NORML’s website: